Results 11 to 20 of about 726,031 (169)

The Core of the Global Corporate Network [PDF]

open access: yesNetworks and Spatial Economics, 2021
AbstractWe investigate the network topology of a comprehensive data set of the world-wide population of corporate entities. In particular, we have extracted information on the boards of all companies listed in Bloomberg’s archive of company profiles in October, 2015, a total of almost 100,000 firms.
Giglio, Ricardo, Lux, Thomas
openaire   +3 more sources

Sharing the cost of a network: core and core allocations [PDF]

open access: yesInternational Journal of Game Theory, 2002
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Maurice Koster   +3 more
openaire   +5 more sources

Core Percolation on Complex Networks [PDF]

open access: yesPhysical Review Letters, 2012
As a fundamental structural transition in complex networks, core percolation is related to a wide range of important problems. Yet, previous theoretical studies of core percolation have been focusing on the classical Erdős-Rényi random networks with Poisson degree distribution, which are quite unlike many real-world networks with scale-free or fat ...
Yang-Yu, Liu   +3 more
openaire   +4 more sources

Emergence of core–peripheries in networks [PDF]

open access: yesNature Communications, 2016
AbstractA number of important transport networks, such as the airline and trade networks of the world, exhibit a characteristic core–periphery structure, wherein a few nodes are highly interconnected and the rest of the network frays into a tree. Mechanisms underlying the emergence of core–peripheries, however, remain elusive. Here, we demonstrate that
Verma, T.   +4 more
openaire   +7 more sources

Integrating patient-reported physical, mental, and social impacts to classify long COVID experiences

open access: yesScientific Reports, 2023
Long COVID was originally identified through patient-reported experiences of prolonged symptoms. Many studies have begun to describe long COVID; however, this work typically focuses on medical records, instead of patient experiences, and lacks a ...
Keri Vartanian   +5 more
doaj   +1 more source

The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies

open access: yesFrontiers in Immunology, 2021
Cetuximab has an established role in the treatment of patients with recurrent/metastatic colorectal cancer and head and neck squamous cell cancer (HNSCC).
Hasan Baysal   +9 more
doaj   +1 more source

Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma

open access: yesBiomedicines, 2022
Malignant pleural mesothelioma (MPM) is a fatal cancer type that affects the membranes lining the lungs, and is causally associated with asbestos exposure. Until recently, the first-line treatment consisted of a combination of chemotherapeutics that only
Sophie Rovers   +6 more
doaj   +1 more source

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers

open access: yesAntioxidants, 2023
Auranofin (AF) is a potent, off-patent thioredoxin reductase (TrxR) inhibitor that efficiently targets cancer via reactive oxygen species (ROS)- and DNA damage-mediated cell death.
Laurie Freire Boullosa   +11 more
doaj   +1 more source

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model

open access: yesPharmaceutics, 2022
The antineoplastic activity of the thioredoxin reductase 1 (TrxR) inhibitor, auranofin (AF), has already been investigated in various cancer mouse models as a single drug, or in combination with other molecules.
Laurie Freire Boullosa   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy